Indonesia starts Covid-19 mass vaccinations on January 13

A batch of Chinese Covid-19 vaccines arrives in Indonesia

Indonesia’s government has said it will begin its nationwide Covid-19 vaccination programme on January 13, according to an announcement by the country’s health minister Budi Gunadi Sadikin on January 5.

President Joko Widodo will to be given the first jab of a vaccine made by China’s Sinovac Biotech.

The mass inoculation programme will begin in the capital Jakarta and the move on to other provinces. The vaccine will be administered for free across the archipelago, with the rollout expected to take 15 months.

The announcement came as Indonesia, which has a population of roughly 270 million people, battles the worst coronavirus outbreak in Southeast Asia. Since it started, the country recorded almost 780,000 cases and more than 23,000 deaths from the virus.

The Indonesian government has previously said 1.3 million frontline workers will be among the first to receive the Sinovac vaccine, named CoronaVac. It has signed a deal for 125.5 million doses of the CoronaVac shot and has already received a first batch of three million doses.

Budi said after health workers are inoculated, regional governors should come forward to be given the vaccine in order to “generate confidence in the community.”

Some people remain skeptical about the vaccine

However, the World Health Organisation in a survey published in August last year reported that the Covid-19 pandemic has further exacerbated vaccine hesitancy in Indonesia, with 27 per cent of respondents saying they were wary of taking a coronavirus inoculation.

Their reasons ranged from fears over safety and efficacy of vaccines to religious beliefs, including concern over the possible use of pork products in the jabs which applies mainly to Muslims.

Sinovac, along with Indonesia’s state-owned drug maker Bio Farma, is currently overseeing late-stage clinical trials in the province of West Java. Early results showed the vaccine was 91.25-per cent effective, while researchers in Brazil have said it was more than 50-per cent effective, though full results were yet to be released at the company’s request.

Pfizer and AstraZeneca vaccines to follow

Overall, Indonesia has secured more than 329 million doses of Covid-19 vaccines, apart from Sinovac also from Pfizer and its partner BioNTech, and from AstraZeneca, which has developed a vaccine together with Oxford University.

The country’s health ministry has previously said that Indonesia must inoculate at least 181.5 million people, or roughly 67 per cent of the population, to reach herd immunity.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

A batch of Chinese Covid-19 vaccines arrives in Indonesia Indonesia’s government has said it will begin its nationwide Covid-19 vaccination programme on January 13, according to an announcement by the country’s health minister Budi Gunadi Sadikin on January 5. President Joko Widodo will to be given the first jab of a vaccine made by China’s Sinovac Biotech. The mass inoculation programme will begin in the capital Jakarta and the move on to other provinces. The vaccine will be administered for free across the archipelago, with the rollout expected to take 15 months. The announcement came as Indonesia, which has a...

A batch of Chinese Covid-19 vaccines arrives in Indonesia

Indonesia’s government has said it will begin its nationwide Covid-19 vaccination programme on January 13, according to an announcement by the country’s health minister Budi Gunadi Sadikin on January 5.

President Joko Widodo will to be given the first jab of a vaccine made by China’s Sinovac Biotech.

The mass inoculation programme will begin in the capital Jakarta and the move on to other provinces. The vaccine will be administered for free across the archipelago, with the rollout expected to take 15 months.

The announcement came as Indonesia, which has a population of roughly 270 million people, battles the worst coronavirus outbreak in Southeast Asia. Since it started, the country recorded almost 780,000 cases and more than 23,000 deaths from the virus.

The Indonesian government has previously said 1.3 million frontline workers will be among the first to receive the Sinovac vaccine, named CoronaVac. It has signed a deal for 125.5 million doses of the CoronaVac shot and has already received a first batch of three million doses.

Budi said after health workers are inoculated, regional governors should come forward to be given the vaccine in order to “generate confidence in the community.”

Some people remain skeptical about the vaccine

However, the World Health Organisation in a survey published in August last year reported that the Covid-19 pandemic has further exacerbated vaccine hesitancy in Indonesia, with 27 per cent of respondents saying they were wary of taking a coronavirus inoculation.

Their reasons ranged from fears over safety and efficacy of vaccines to religious beliefs, including concern over the possible use of pork products in the jabs which applies mainly to Muslims.

Sinovac, along with Indonesia’s state-owned drug maker Bio Farma, is currently overseeing late-stage clinical trials in the province of West Java. Early results showed the vaccine was 91.25-per cent effective, while researchers in Brazil have said it was more than 50-per cent effective, though full results were yet to be released at the company’s request.

Pfizer and AstraZeneca vaccines to follow

Overall, Indonesia has secured more than 329 million doses of Covid-19 vaccines, apart from Sinovac also from Pfizer and its partner BioNTech, and from AstraZeneca, which has developed a vaccine together with Oxford University.

The country’s health ministry has previously said that Indonesia must inoculate at least 181.5 million people, or roughly 67 per cent of the population, to reach herd immunity.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

NO COMMENTS

Leave a Reply